iciHaiti - Heritage : Did you know ?

iciHaiti - Security : Results of the General Inspectorate of the National Police (July 2015)

iciHaiti - Agriculture : «Chic Poulet» produces 4 million eggs per month

iciHaiti - Agriculture : RD denies that its wheat flour contains carcinogenic additives

iciHaiti - Social : Soon a demonstration in Petit-Goâve


more news


Haiti - FLASH : Getheau Lindor candidate for deputy of Petit-Goâve, abandons

Haiti - NOTICE : You have only 6 days to withdraw your CIN

Haiti - Sports : 10 medals for Haiti at Special Olympics in Los Angeles

Haiti - Technology : Clinical studies of a new tuberculosis diagnostic device

Haiti - FLASH : New electoral violence in Petit-Goâve


more news


Haiti - Health : A vaccine will be tested in Haiti
19/10/2011 14:09:48

Haiti - Health : A vaccine will be tested in Haiti
The Ministry of Public Health and Population (MSPP) will soon conduct a test vaccination against cholera on a hundred subjects from a slum in Port-au-Prince and a rural community in the center of the country, where the disease was first identified in October 2010, according to information obtained by AFP from Dr. Gabriel Timothé, Director General of the Ministry of Health of Haiti.

The vaccine Shanchol will be administered orally to patients, in two doses. The vaccine approved by the World Health Organization (WHO) will not replace awareness among the population said Dr. Timothé.

There are 3 brands of vaccine against cholera in the world: Dukoral ($40 per dose) is manufactured in Sweden and approved by the WHO, Shanchol, now approved by WHO, ($6 per dose - $1,00 per dose with sufficient demand) is produced by Shantha Biotechnics in India and the Morc VAX-VaBiotech is produced in Vietnam.

International Vaccine Institute scientists developed this vaccine, with funding from the Bill & Melinda Gates Foundation, the Government of Korea, and the Swedish International Development Cooperation Agency (SIDA), by significantly modifying a vaccine used and produced only in Vietnam so that it meets international Good Manufacturing Practice (GMP) standards and WHO production guidelines.

The trial in Calcutta (India), which enrolled nearly 70,000 people, has shown that the vaccine provides 67% protection for at least two years in this highly-endemic population.

Vaccination against cholera, true or false hopes ?
http://www.haitilibre.com/en/news-1986-haiti-epidemic-vaccination-against-cholera-true-or-false-hopes.html

See also :
http://www.haitilibre.com/en/news-4053-haiti-health-cholera-already-one-year.html

HL/ HaitiLibre

Twitter Facebook Rss Add to favorites
Send news to... Daily news...




Why HaitiLibre ? | Contact us | Français
Copyright © 2010 - 2015
Haitilibre.com